Synthesis process of dasatinib and intermediate thereof
US9108954B2 · kind B2 · utility
7Cited by
0References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 30, 2011 |
| Grant date | Aug 18, 2015 |
| Priority date | — |
| Expiry date | Oct 18, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Synthesis process of dasatinib is disclosed, which includes the step of reacting the compound of formula I with that of formula II to obtain the compound of formula III. Also disclosed is the compound of formula III which is used as an intermediate for synthesizing dasatinib. The substituents of R1, R2, R3 or R4 in formulae I, II or III are defined as in the description.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.